. Author manuscript; available in PMC: 2011 Jun 1.

Published in final edited form as: Sex Transm Infect. 2010 Apr 21;86(3):202–206. doi: 10.1136/sti.2009.039735

Table 3.

Poisson regressions for shedding and lesions.

	genital shedding		oral shedding
	RR (95% C.I.^a)	P	RR (95% C.I.^a)	P
any APOE4 versus none	0.94 (0.68–1.29)	0.69	1.65 (0.69–3.97)	0.26
any APOE4 versus none^b	0.93 (0.68–1.29)	0.68	1.61 (0.68–3.79)	0.28
male gender	0.87 (0.64–1.18)	0.37	1.41 (0.58–3.46)	0.45
HSV-1 and HSV-2 infection	1.23 (0.91–1.67)	0.17	3.35 (0.52–21.77)	0.21
	genital lesions		oral lesions
	RR (95% C.I.^a)	P	RR (95% C.I.^a)	P
any APOE4 versus none	0.93 (0.61–1.41)	0.72	4.64 (1.32–15.05)	0.016
any APOE4 versus none^b	0.86 (0.57–1.29)	0.45	4.04 (1.09–15.01)	0.037
male gender	1.02 (0.69–1.52)	0.91	1.57 (0.37–6.59)	0.54
HSV-1 and HSV-2 infection	1.08 (0.73–1.60)	0.70	0.74 (0.16–3.39)	0.70
history of genital herpes	5.13 (2.20–11.98)	<0.001	--	--

C.I. stands for confidence interval.

Risk ratio adjusted for gender, co-infection, time since infection, and symptoms at site. Data set on oral symptoms is incomplete so no adjustment is made for oral shedding.